carmustine has been researched along with Angiogenesis, Pathologic in 6 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Additionally, we compared the antitumoral effect of protamine with that of another inhibitor of angiogenesis, suramin, and investigated a potential synergistic antitumoral action of low doses of protamine combined with the antineoplastic carmustine." | 5.30 | Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine. ( Arrieta, O; Guevara, P; Ortiz, A; Rembao, D; Reyes, S; Sotelo, J, 1998) |
| " Additionally, we investigated a potential enhancement of the antitumoral action of thalidomide when combined with a low dose of the antineoplastic carmustine." | 1.31 | Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma. ( Arrieta, O; Guevara, P; Rembao, D; Rivera, E; Sotelo, J; Tamariz, J, 2002) |
| " Additionally, we compared the antitumoral effect of protamine with that of another inhibitor of angiogenesis, suramin, and investigated a potential synergistic antitumoral action of low doses of protamine combined with the antineoplastic carmustine." | 1.30 | Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine. ( Arrieta, O; Guevara, P; Ortiz, A; Rembao, D; Reyes, S; Sotelo, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moffat, BA | 1 |
| Chen, M | 1 |
| Kariaapper, MS | 1 |
| Hamstra, DA | 1 |
| Hall, DE | 1 |
| Stojanovska, J | 1 |
| Johnson, TD | 1 |
| Blaivas, M | 1 |
| Kumar, M | 1 |
| Chenevert, TL | 1 |
| Rehemtulla, A | 1 |
| Ross, BD | 1 |
| Kakeji, Y | 1 |
| Teicher, BA | 2 |
| Ma, J | 1 |
| Fei, ZL | 1 |
| Klein-Szanto, A | 1 |
| Gallo, JM | 1 |
| Arrieta, O | 2 |
| Guevara, P | 2 |
| Reyes, S | 1 |
| Ortiz, A | 1 |
| Rembao, D | 2 |
| Sotelo, J | 2 |
| Menon, K | 1 |
| Alvarez, E | 1 |
| Galbreath, E | 1 |
| Shih, C | 1 |
| Faul, M | 1 |
| Tamariz, J | 1 |
| Rivera, E | 1 |
6 other studies available for carmustine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood Flow Velocity; Blood Volume; Brain Neoplasms; Carm | 2006 |
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Anti | 1997 |
Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.
Topics: Animals; Antineoplastic Agents, Alkylating; Capillaries; Carmustine; Cell Hypoxia; Dacarbazine; DNA, | 1998 |
Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Cell Division; Dose-Response Relationship, D | 1998 |
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell | 2001 |
Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell D | 2002 |